Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Dialysis access · Florida | Dialysis access · Texas | |
|---|---|---|
| Surgeons, 2024 | 93 | 153 |
| Medicare fee-for-service cases | 10,783 | 14,652 |
| Growth since 2019 (Medicare FFS) | −15%/yr | −16%/yr |
| Forecast cases (Medicare FFS) | 10,100 in 2030 | 14,800 in 2030 |
| Forecast growth | −1%/yr to 2030 | +0.2%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 5.0 | 7.1 |
| Medicare Advantage share | 60% | 59% |
| Out of hospital | 68% (+2 pts since 2019) | 71% (−1 pts since 2019) |
| Cases per surgeon | 116 | 96 |
| Top 10 surgeons' share | 48% | 26% |
| Surgeons growing | 7 | 8 |
| New since the base year | 8 | 21 |
| Likely to stop billing it | 21 by 2026 | 20 by 2026 |
| Forecast miss, 1 year (procedure) | 4% | 4% |
| Company payments per surgeon | $274 | $148 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.